DTC Telehealth for Europe

The medicine you need. Without the awkward conversation.

Velomed brings discreet, fast prescriptions to Spain. Complete a medical intake, get reviewed by a licensed physician, pick up at any pharmacy. No waiting room. No judgment.

47M

People in Spain

0

DTC telehealth brands

5 min

Average intake time

The Problem

Millions of people avoid their doctor because the conversation feels impossible.

😬

Stigma is real

Erectile dysfunction, hair loss, sexual health. These are medical conditions, not character flaws. But the doctor's office makes them feel that way.

Access is broken

Referrals to specialists, weeks-long wait times, 15-minute appointments that feel like interrogations. The system was built for doctors, not patients.

🌎

Europe got left behind

The US has Hims, Ro, and SesameCare. The UK and Germany have Zava. Spain? Nothing. 47 million people with zero modern options.

How It Works

Three steps. No appointment.

1

Complete the intake

Answer a confidential medical questionnaire from your phone. Same questions a doctor would ask, on your own time.

2

Physician review

A licensed Spanish physician reviews your answers and, if appropriate, writes an e-prescription. No video call required.

3

Pick up anywhere

Your prescription is sent to any pharmacy in Spain. Walk in, collect your medication. Discreet, fast, done.

The Opportunity

A proven model meets an untouched market.

DTC telehealth generated $1.2B+ in the US last year. The EU is 3-5 years behind. We're here to close that gap, starting with Spain.

$1.2B+

Hims & Hers annual revenue. The DTC model is proven at scale.

40%+

Of ED prescriptions in Spain now issued via telemedicine. Patients want this.

27 EU

Countries with cross-border prescription recognition. One platform, continental reach.

2025

EU Health Data Space regulation launched. The regulatory tailwind is here.

Healthcare should be as easy as it is private.

Velomed is building the future of accessible, stigma-free medicine in Europe. Starting in Spain. Expanding across the EU. One prescription at a time.